Developer docs
API playgroundTry for free, no card

Search company profiles

Triventures

Full company profile

uuid00005ju

Namestring
Triventures
Legal namestring
Triventures
Websiteurl
triventures.vc
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Triventures is a global venture capital fund founded in 2010 that invests in early-stage companies across healthcare and adjacent sectors including fintech, cybersecurity, and B2B2C. The firm operates two investment vehicles: the core Triventures VC Fund, which invests from pre-seed through Series D and IPO, and Triventures ARC, a seed-stage digital health sub-fund established in partnership with Sheba Medical Center, Israel's largest university-affiliated teaching hospital. The ARC vehicle provides portfolio companies privileged access to Sheba's clinical data assets and an international network of affiliated hospitals across North America and Europe. The fund is co-led by Managing Partners Michal Geva (medtech/digital health operator with exits at Stryker, TransEnterix, Thoratec, and 1-800 Contacts) and Dr. Peter Fitzgerald (Stanford interventional cardiologist and founder of 24 healthcare companies, 18 transitioned to mid/large-cap), with Dr. Martin Leon (Columbia University, founder of CRF and TCT) as Co-Founder and Venture Partner. Triventures generates revenue through conventional VC fund economics — management fees charged to Limited Partners and carried interest on portfolio company exits — and has realized more than 30 exits across its history, including recent acquisitions of CathWorks by Medtronic (2023), V-Wave by Johnson & Johnson (2024), Day Zero Diagnostics by bioMérieux (2025), and Genoox by Qiagen (2025). The firm's Limited Partner base comprises tier-1 strategic corporate investors whose combined market value exceeds $1 trillion, including Medtronic, Abbott, Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Philips, Samsung, NTT, Intermountain Healthcare, and Baptist Health Innovations, with offices in Tel Aviv (Israel HQ) and Portola Valley (Silicon Valley, US).

Short descriptiontext

Triventures is a global venture capital fund founded in 2010 that invests from pre-seed to IPO in healthcare, fintech, and cybersecurity, with a specialized digital health sub-fund (Triventures ARC) partnered with Sheba Medical Center and a tier-1 strategic corporate LP base including Medtronic, J&J, Abbott, and Samsung.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTel Aviv, Israel
HQ citystring
Tel Aviv
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital fund, healthcare investments, early-stage investing, digital health funding, medical device investment
Industry1 code
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
NAICS code2 codes
  • Other Investment Pools and Funds5259
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeSubscription Recurring
Description

As a venture capital fund, Triventures generates revenue through management fees charged to Limited Partners (LPs) and carried interest (carry) from successful portfolio company exits.

triventures.vc
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Triventures ARC
Description

A seed-stage digital healthcare and smart medical devices fund operated in partnership with Sheba Medical Center's ARC Innovation Center.

triventures.vc
Core offering1 text field

Triventures is a global venture capital fund that invests capital and provides strategic guidance into early-stage companies in healthcare, digital health, fintech, cybersecurity, and adjacent sectors, typically from pre-seed through Series D and IPO. Its primary offering is fund management for Limited Partners, complemented by a specialized seed-stage digital health sub-fund (Triventures ARC) operated in partnership with Sheba Medical Center that gives portfolio companies direct access to clinical data and hospital networks.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Triventures operates as a unified venture capital fund with a specialized healthcare focus. The fund comprises two primary investment vehicles: the core Triventures VC Fund that makes early-stage investments across healthcare, fintech, cybersecurity, and e-commerce, and the Triventures ARC sub-fund which focuses specifically on digital health and smart medical devices in partnership with Sheba Medical Center. The ARC program provides portfolio companies with access to Sheba's vast health data assets and international hospital network.

Product and service2 records
1Triventures VC Fund
CategoryVenture Capital Fund
Description

A global venture capital fund that invests in early-stage companies with validated business models across healthcare, fintech, cybersecurity, and e-commerce, with strategic presence in the US, Israel, and Canada. Investments span pre-seed through Series D and IPO stages, targeting bio-convergence and data-driven technologies. Investors are institutional Limited Partners and strategic corporate partners; capital is deployed via direct equity rounds into portfolio companies.

2Triventures ARC Fund
CategorySeed-Stage Digital Health Fund
Description

A seed-stage digital healthcare and smart medical devices fund operated in partnership with Sheba Medical Center's ARC Innovation Center. Portfolio companies gain direct access to Sheba's clinical data assets and Sheba's network of affiliated hospitals in North America and Europe, plus the broader ARC innovation ecosystem. Triventures ARC is the venture capital arm of the ARC Innovation Center, a health-tech hub inside Sheba Medical Center.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Triventures partnered with Sheba Medical Center, Israel's largest university-affiliated teaching hospital (recognized by Newsweek as one of the world's top ten hospitals), to establish Triventures ARC. Portfolio companies benefit from Sheba's data assets and network of affiliated hospitals in North America and Europe.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

a16z's Bio/Health fund is a leading digital health and bio-convergence investor with multi-hundred-million-dollar fund vintages, directly comparable to Triventures' thesis and stage focus.

TypeDirect peer
Description

Khosla has been a long-standing digital health and bio-tech seed-to-growth investor, overlapping directly with Triventures' early-stage healthcare focus.

TypeDirect peer
Description

BVP's healthcare practice and growth-stage investing model parallels Triventures' strategy of backing health-tech companies from early-stage through exit, including IPO-stage opportunities.

TypeDirect peer
Description

NEA is a multi-stage healthcare-focused investor with deep life sciences and digital health portfolios, directly competing for the same founder relationships and exit partners.

TypeDirect peer
Description

General Catalyst's Health Assurance and bio bets overlap materially with Triventures' digital health thesis, including transformation-of-care investments and tier-1 LP relationships.

TypeDirect peer
Description

GV invests across life sciences and digital health at seed-to-growth stages, with a similarly global footprint and strategic LP-style engagement with portfolio founders.

TypeDirect peer
Description

Section32 is a digital health-dedicated venture fund investing at seed and Series A — a near-direct competitor to Triventures ARC in the digital health seed market.

TypeDirect peer
Description

Define Ventures is an early-stage digital health-only fund with tier-1 strategic LP backing, directly comparable to Triventures' positioning around healthcare transformation.

TypeDirect peer
Description

Lux invests at the intersection of science, technology, and health, with comparable bio-convergence thesis and early-stage healthcare bets overlapping Triventures' portfolio.

TypeDirect peer
Description

Optum Ventures is a corporate-led digital health investor backed by UnitedHealth Group, directly comparable as a strategic-corporate-LP-driven digital health investor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment59 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Triventures

Healthcare Venture Capitaltriventures.vc

Triventures is a global venture capital fund founded in 2010 that invests from pre-seed to IPO in healthcare, fintech, and cybersecurity, with a specialized digital health sub-fund (Triventures ARC) partnered with Sheba Medical Center and a tier-1 strategic corporate LP base including Medtronic, J&J, Abbott, and Samsung.

What Triventures does

Triventures is a global venture capital fund founded in 2010 that invests in early-stage companies across healthcare and adjacent sectors including fintech, cybersecurity, and B2B2C. The firm operates two investment vehicles: the core Triventures VC Fund, which invests from pre-seed through Series D and IPO, and Triventures ARC, a seed-stage digital health sub-fund established in partnership with Sheba Medical Center, Israel's largest university-affiliated teaching hospital. The ARC vehicle provides portfolio companies privileged access to Sheba's clinical data assets and an international network of affiliated hospitals across North America and Europe. The fund is co-led by Managing Partners Michal Geva (medtech/digital health operator with exits at Stryker, TransEnterix, Thoratec, and 1-800 Contacts) and Dr. Peter Fitzgerald (Stanford interventional cardiologist and founder of 24 healthcare companies, 18 transitioned to mid/large-cap), with Dr. Martin Leon (Columbia University, founder of CRF and TCT) as Co-Founder and Venture Partner. Triventures generates revenue through conventional VC fund economics — management fees charged to Limited Partners and carried interest on portfolio company exits — and has realized more than 30 exits across its history, including recent acquisitions of CathWorks by Medtronic (2023), V-Wave by Johnson & Johnson (2024), Day Zero Diagnostics by bioMérieux (2025), and Genoox by Qiagen (2025). The firm's Limited Partner base comprises tier-1 strategic corporate investors whose combined market value exceeds $1 trillion, including Medtronic, Abbott, Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Philips, Samsung, NTT, Intermountain Healthcare, and Baptist Health Innovations, with offices in Tel Aviv (Israel HQ) and Portola Valley (Silicon Valley, US).

Triventures firmographics

Firmographics
Name
Triventures
Legal name
Triventures
Website
https://triventures.vc
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
Triventures is a global venture capital fund founded in 2010 that invests from pre-seed to IPO in healthcare, fintech, and cybersecurity, with a specialized digital health sub-fund (Triventures ARC) partnered with Sheba Medical Center and a tier-1 strategic corporate LP base including Medtronic, J&J, Abbott, and Samsung.
Ownership category
akta.pro rank

Triventures industry classification

Industry
Product category
Healthcare Venture Capital
NAICS
Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAM
Accelerators & Incubators (Investor-Operated)

Keywords

  • Venture capital fund
  • Healthcare investments
  • Early-stage investing
  • Digital health funding
  • Medical device investment

Where Triventures is headquartered

Location

Headquarters

HQ city
Tel Aviv
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

Triventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Fund Management: As a venture capital fund, Triventures generates revenue through management fees charged to Limited Partners (LPs) and carried interest (carry) from successful portfolio company exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Triventures product offering

Product offering

Core offering

Triventures is a global venture capital fund that invests capital and provides strategic guidance into early-stage companies in healthcare, digital health, fintech, cybersecurity, and adjacent sectors, typically from pre-seed through Series D and IPO. Its primary offering is fund management for Limited Partners, complemented by a specialized seed-stage digital health sub-fund (Triventures ARC) operated in partnership with Sheba Medical Center that gives portfolio companies direct access to clinical data and hospital networks.

Product overview

Triventures operates as a unified venture capital fund with a specialized healthcare focus. The fund comprises two primary investment vehicles: the core Triventures VC Fund that makes early-stage investments across healthcare, fintech, cybersecurity, and e-commerce, and the Triventures ARC sub-fund which focuses specifically on digital health and smart medical devices in partnership with Sheba Medical Center. The ARC program provides portfolio companies with access to Sheba's vast health data assets and international hospital network.

Differentiator

Problem solved

Functional benefit

Brands

  • Triventures ARC: A seed-stage digital healthcare and smart medical devices fund operated in partnership with Sheba Medical Center's ARC Innovation Center.

Products and services

  • Triventures VC Fund A global venture capital fund that invests in early-stage companies with validated business models across healthcare, fintech, cybersecurity, and e-commerce, with strategic presence in the US, Israel, and Canada. Investments span pre-seed through Series D and IPO stages, targeting bio-convergence and data-driven technologies. Investors are institutional Limited Partners and strategic corporate partners; capital is deployed via direct equity rounds into portfolio companies.
  • Triventures ARC Fund A seed-stage digital healthcare and smart medical devices fund operated in partnership with Sheba Medical Center's ARC Innovation Center. Portfolio companies gain direct access to Sheba's clinical data assets and Sheba's network of affiliated hospitals in North America and Europe, plus the broader ARC innovation ecosystem. Triventures ARC is the venture capital arm of the ARC Innovation Center, a health-tech hub inside Sheba Medical Center.

Companies that use Triventures

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Triventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Triventures partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sheba Medical CentercoreStrategic or Co-development PartnerTriventures partnered with Sheba Medical Center, Israel's largest university-affiliated teaching hospital (recognized by Newsweek as one of the world's top ten hospitals), to establish Triventures ARC. Portfolio companies benefit from Sheba's data assets and network of affiliated hospitals in North America and Europe.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Triventures competitors and assessment

Company assessment

Direct peers

  • Andreessen Horowitz (a16z Bio): a16z's Bio/Health fund is a leading digital health and bio-convergence investor with multi-hundred-million-dollar fund vintages, directly comparable to Triventures' thesis and stage focus.
  • Khosla Ventures: Khosla has been a long-standing digital health and bio-tech seed-to-growth investor, overlapping directly with Triventures' early-stage healthcare focus.
  • Bessemer Venture Partners: BVP's healthcare practice and growth-stage investing model parallels Triventures' strategy of backing health-tech companies from early-stage through exit, including IPO-stage opportunities.
  • New Enterprise Associates (NEA): NEA is a multi-stage healthcare-focused investor with deep life sciences and digital health portfolios, directly competing for the same founder relationships and exit partners.
  • General Catalyst: General Catalyst's Health Assurance and bio bets overlap materially with Triventures' digital health thesis, including transformation-of-care investments and tier-1 LP relationships.
  • GV (Google Ventures): GV invests across life sciences and digital health at seed-to-growth stages, with a similarly global footprint and strategic LP-style engagement with portfolio founders.
  • Section32: Section32 is a digital health-dedicated venture fund investing at seed and Series A — a near-direct competitor to Triventures ARC in the digital health seed market.
  • Define Ventures: Define Ventures is an early-stage digital health-only fund with tier-1 strategic LP backing, directly comparable to Triventures' positioning around healthcare transformation.
  • Lux Capital: Lux invests at the intersection of science, technology, and health, with comparable bio-convergence thesis and early-stage healthcare bets overlapping Triventures' portfolio.
  • Optum Ventures: Optum Ventures is a corporate-led digital health investor backed by UnitedHealth Group, directly comparable as a strategic-corporate-LP-driven digital health investor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Triventures social profiles

Digital presence

Triventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Triventures leadership team

Management profile

Number of profiles

Profiles8 records

Triventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Triventures M&A and investment

M&A and investment

M&A

Investments59 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Triventures

What does Triventures do?

Triventures is a global venture capital fund that invests capital and provides strategic guidance into early-stage companies in healthcare, digital health, fintech, cybersecurity, and adjacent sectors, typically from pre-seed through Series D and IPO. Its primary offering is fund management for Limited Partners, complemented by a specialized seed-stage digital health sub-fund (Triventures ARC) operated in partnership with Sheba Medical Center that gives portfolio companies direct access to clinical data and hospital networks.

Is Triventures a public or private company?

Triventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Triventures founded?

Triventures was founded in 2010. It employs 1 to 10 people.

Where is Triventures based?

Triventures is headquartered in Tel Aviv, Israel, in the Middle East region.

How does Triventures make money?

One revenue line is on record: fund Management.

Who are Triventures's main competitors?

Direct peers on record are Andreessen Horowitz (a16z Bio), Khosla Ventures, Bessemer Venture Partners, New Enterprise Associates (NEA), General Catalyst, GV (Google Ventures), Section32, Define Ventures, Lux Capital and Optum Ventures.

Does Triventures have an API?

No public API is recorded for Triventures.

What industry is Triventures in?

Triventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireStart-Up Nation Central Announces CatAI is Winner of Hospital2Hospital Clinical Capacity Tech Challenge with U.S.-based Baptist Health South Florida, Sheba ARC Innovation, and TriventuresStart-Up Nation Central announced that CatAI won its inaugural Hospital2Hospital Clinical Capacity Tech Challenge, selected from 106 competing companies. CatAI will receive a $75,000 in-kind pilot credit to work with Baptist Health Innovations and further develop its AI-powered digital healthcare platform that extracts medical data through a smartphone camera for the U.S. market. The challenge, conducted in partnership with Sheba ARC Innovation and Triventures, aimed to leverage Israeli healthcare innovation to address global hospital efficiency challenges.CTechCapitola secures $15.6 million Series A for marketplace for commercial insuranceCapitola, a Tel Aviv-based digital marketplace for commercial insurance, secured $15.6 million in Series A funding led by Munich Re Ventures with participation from Lightspeed Venture Partners and TriVentures. The company intends to use the capital to enhance its market intelligence capabilities and accelerate sales expansion in the United States.FinSMEsChargeFUZE Raises $5M in Seed FundingChargeFUZE, a mobile charging kiosk company, raised $5M in seed funding from backers including Beverly Pacific and TR Ventures. The company plans to use the funds to scale its team and expand its network of autonomous kiosks, which currently span over 40 states and include major sports venues.Business Wire BlogGrin Closes $14M Round With P&G, Triventures, and SpringRock Ventures To Modernize Teledentistry at ScaleGrin, a digital orthodontic platform, closed a $10M funding round led by Triventures with participation from P&G and SpringRock Ventures, bringing total funding to $14M. The funds will support technological innovations, talent, and expansion of its orthodontic partner network across the US.PR NewswireBioProtect Announces Final Closing of Equity Financing at $25M To Protect Prostate Cancer PatientsBioProtect announced the final closing of a $25 million Series D equity financing round led by Almeda Ventures and Vincent Tchenguiz, with participation from Peregrine Ventures, KB Investments, and Triventures. The proceeds will fund the ongoing multicenter FDA clinical trial for its lead product, ProSpace™ balloon spacer, which is designed to protect prostate cancer patients undergoing radiation therapy.GlobeNewswireKaltura to Power ‘Health & Tech – Now & Beyond’ Virtual Event, Hosted by AWS and TriventuresKaltura announced its virtual events platform will power the 'Health & Tech – Now & Beyond' event on July 29, hosted by AWS and Triventures. The event features keynotes and a startup panel on healthcare technology, with Kaltura providing interactive virtual tools. The company highlights the $10.5 trillion health-tech market and calls for cross-industry innovation.FinSMEsDay Zero Diagnostics Completes $8.6M Series A FundingDay Zero Diagnostics completed an $8.6M Series A funding round led by Triventures, with participation from existing investors. The company will use the funds to accelerate prototype development of its sample preparation technology and introduce DZD Lab Services. The Boston-based firm develops sequencing-based rapid diagnostics for bacterial pathogens.FinSMEsSheba Medical Center and Triventures Team Up to Accelerate Healthcare InnovationsSheba Medical Center and Triventures launched Triventures ARC, a $45M fund for seed investments in healthcare innovations. The fund targets data-driven solutions in personalized healthcare, AI, and smart devices, with access to Sheba's 25-year patient data. It is the first partnership between an Israeli healthcare system and a venture capital fund.PrwebIsrael's Largest Hospital Sheba Medical Center and Venture Capital Fund Triventures Partner to Accelerate Healthcare InnovationsSheba Medical Center and Triventures launched Triventures ARC, a venture capital arm to fund seed investments in healthcare innovations. The $45M fund targets data-driven health solutions, including personalized care and AI, with access to Sheba's 25-year patient data. The partnership aims to accelerate start-ups' development through data and clinical access.FinSMEsGenoox Raises $6M in Funding Round Led by TriventuresGenoox, a Palo Alto-based genomic analysis company, closed a $6M funding round led by Triventures, with Inimiti Capital and Glilot Capital Partners participating. The funds will support expansion of operations and business reach to more U.S. medical facilities. The company also partnered with Bionano Genomics in April to enhance detection of structural variants.